Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jonathan Kaufman

Concepts (263)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cardiac Surgical Procedures
11
2020
414
1.940
Why?
Intensive Care Units, Pediatric
7
2020
148
1.880
Why?
Heart Defects, Congenital
11
2020
671
1.600
Why?
Postoperative Complications
9
2020
2128
1.020
Why?
Quality Improvement
3
2018
950
0.980
Why?
Hyponatremia
2
2016
37
0.960
Why?
Enteral Nutrition
7
2020
160
0.800
Why?
Antineoplastic Combined Chemotherapy Protocols
8
2022
1356
0.730
Why?
Intensive Care Units
5
2020
617
0.710
Why?
Multiple Myeloma
4
2022
98
0.690
Why?
Infant, Newborn
23
2020
5047
0.690
Why?
Airway Extubation
1
2020
43
0.660
Why?
Vascular Access Devices
1
2018
24
0.590
Why?
Cardiac Care Facilities
1
2017
13
0.590
Why?
Postoperative Care
3
2014
222
0.590
Why?
Heart Diseases
3
2016
331
0.560
Why?
Hypernatremia
1
2016
7
0.550
Why?
Hypoplastic Left Heart Syndrome
2
2014
109
0.520
Why?
Vasodilator Agents
3
2013
302
0.510
Why?
Stem Cell Transplantation
2
2022
149
0.510
Why?
Infant
17
2020
7964
0.490
Why?
Boronic Acids
3
2014
33
0.470
Why?
Infant, Premature
3
2020
476
0.470
Why?
Tachycardia
2
2014
50
0.470
Why?
Pyrazines
3
2014
71
0.460
Why?
Unnecessary Procedures
1
2014
44
0.460
Why?
Blood Chemical Analysis
1
2014
90
0.450
Why?
Parenteral Nutrition
1
2015
96
0.450
Why?
Milrinone
1
2013
24
0.440
Why?
Norwood Procedures
1
2013
22
0.440
Why?
Calcitonin
1
2013
23
0.430
Why?
Critical Illness
2
2016
646
0.430
Why?
Cardiovascular Surgical Procedures
1
2013
29
0.430
Why?
Dexamethasone
5
2022
317
0.430
Why?
Prilocaine
1
2013
3
0.430
Why?
Methemoglobinemia
1
2013
13
0.420
Why?
Lidocaine
1
2013
40
0.420
Why?
Thrombosis
2
2018
298
0.420
Why?
Tidal Volume
1
2013
75
0.410
Why?
Protein Precursors
1
2013
119
0.410
Why?
Nutritional Status
1
2015
287
0.410
Why?
Masks
1
2013
46
0.410
Why?
Continuous Positive Airway Pressure
1
2013
51
0.400
Why?
Anesthetics, Local
1
2013
81
0.400
Why?
Bronchiolitis
1
2013
81
0.400
Why?
Cardiac Output, Low
1
2012
64
0.390
Why?
Weight Gain
1
2015
453
0.380
Why?
Length of Stay
6
2018
962
0.380
Why?
Cardiotonic Agents
1
2012
119
0.380
Why?
Catheter Obstruction
1
2011
3
0.370
Why?
C-Reactive Protein
1
2013
362
0.370
Why?
Retrospective Studies
17
2020
12556
0.360
Why?
Chylothorax
1
2010
11
0.360
Why?
Octreotide
1
2010
26
0.360
Why?
Heart Rate
1
2013
709
0.340
Why?
Seizures
1
2013
340
0.340
Why?
Thoracic Surgical Procedures
1
2010
57
0.340
Why?
Extracorporeal Membrane Oxygenation
2
2012
241
0.340
Why?
Catheterization, Central Venous
1
2011
83
0.340
Why?
Gastrostomy
2
2020
91
0.330
Why?
Heparin
1
2011
224
0.330
Why?
Abnormalities, Multiple
1
2011
178
0.330
Why?
Palliative Care
1
2015
644
0.320
Why?
Lymphoma, Non-Hodgkin
3
2015
71
0.310
Why?
Vasculitis
1
2008
66
0.300
Why?
Antibodies, Monoclonal, Murine-Derived
4
2013
82
0.300
Why?
Humans
40
2022
114705
0.290
Why?
Male
30
2020
55607
0.290
Why?
Sepsis
1
2013
509
0.290
Why?
Colorado
5
2020
4100
0.280
Why?
Critical Care
1
2011
476
0.280
Why?
Bortezomib
6
2022
41
0.270
Why?
Female
29
2020
59521
0.270
Why?
Respiration, Artificial
3
2020
529
0.260
Why?
Biomarkers
3
2016
3408
0.240
Why?
Incidence
5
2020
2313
0.240
Why?
Follow-Up Studies
7
2020
4411
0.230
Why?
Intubation, Intratracheal
2
2020
216
0.230
Why?
Enterocolitis, Necrotizing
2
2018
28
0.220
Why?
Child, Preschool
11
2019
9118
0.220
Why?
Intubation, Gastrointestinal
2
2020
56
0.220
Why?
Acute Kidney Injury
4
2020
638
0.220
Why?
Cohort Studies
5
2019
4895
0.210
Why?
Prospective Studies
6
2018
6220
0.210
Why?
Maintenance Chemotherapy
1
2022
22
0.200
Why?
Child
11
2020
18420
0.200
Why?
Disease-Free Survival
5
2022
620
0.200
Why?
Cyclophosphamide
5
2020
217
0.190
Why?
Risk Factors
8
2020
8632
0.190
Why?
Drug Administration Schedule
6
2014
718
0.190
Why?
Cyanosis
1
2020
15
0.180
Why?
Immunoglobulin Light-chain Amyloidosis
1
2020
4
0.180
Why?
Rituximab
5
2015
150
0.170
Why?
Time Factors
6
2013
6116
0.170
Why?
Analysis of Variance
2
2013
1226
0.170
Why?
Fundoplication
1
2020
53
0.170
Why?
Treatment Outcome
10
2020
9088
0.170
Why?
Calcaneus
1
2019
57
0.160
Why?
Ketorolac
1
2018
16
0.160
Why?
Platelet Aggregation
1
2018
94
0.150
Why?
Gastroesophageal Reflux
1
2020
234
0.150
Why?
Catheters, Indwelling
1
2018
79
0.140
Why?
Combined Modality Therapy
2
2010
1121
0.140
Why?
Morphine
1
2018
121
0.140
Why?
Dose-Response Relationship, Drug
4
2014
1842
0.140
Why?
Pain, Postoperative
1
2018
191
0.130
Why?
Diuretics
1
2016
66
0.130
Why?
Prognosis
5
2018
3330
0.130
Why?
Spectroscopy, Near-Infrared
1
2016
47
0.130
Why?
Sodium
1
2016
183
0.130
Why?
Bone Density
1
2019
432
0.130
Why?
Lymphoma, Follicular
2
2015
35
0.130
Why?
Logistic Models
4
2014
1841
0.120
Why?
Gestational Age
2
2020
760
0.120
Why?
Hypertension, Pulmonary
1
2005
1729
0.120
Why?
Heart
1
2018
612
0.110
Why?
Remission Induction
2
2014
233
0.110
Why?
Calcitonin Gene-Related Peptide
1
2013
31
0.110
Why?
Pediatrics
2
2011
981
0.110
Why?
Lung
1
2005
3561
0.110
Why?
Port-Wine Stain
1
2013
2
0.110
Why?
Down Syndrome
1
2018
335
0.110
Why?
Delivery Rooms
1
2013
6
0.110
Why?
Liver Function Tests
1
2013
103
0.110
Why?
Administration, Topical
1
2013
138
0.100
Why?
Survival Rate
2
2013
1644
0.100
Why?
Equipment Failure
1
2013
106
0.100
Why?
Statistics, Nonparametric
1
2013
385
0.100
Why?
Intubation
1
2012
4
0.100
Why?
Health Care Surveys
2
2011
539
0.100
Why?
Australia
1
2013
206
0.100
Why?
Respiration
1
2013
180
0.100
Why?
Pentobarbital
1
2011
16
0.100
Why?
Patient Admission
1
2013
176
0.100
Why?
Status Epilepticus
1
2011
32
0.100
Why?
Vein of Galen Malformations
1
2011
2
0.090
Why?
Hematopoietic Stem Cell Mobilization
1
2011
20
0.090
Why?
Peripheral Blood Stem Cell Transplantation
1
2011
19
0.090
Why?
Respiratory Function Tests
1
2013
522
0.090
Why?
Heterocyclic Compounds
1
2011
18
0.090
Why?
Professional Practice
1
2011
62
0.090
Why?
Linear Models
1
2013
768
0.090
Why?
Analgesics, Opioid
1
2018
771
0.090
Why?
Receptors, CXCR4
1
2011
78
0.090
Why?
Lymphoma, B-Cell
1
2012
86
0.090
Why?
Airway Obstruction
1
2013
168
0.090
Why?
Nutritional Support
1
2010
27
0.090
Why?
Anesthetics, Intravenous
1
2010
27
0.090
Why?
Intracranial Arteriovenous Malformations
1
2011
51
0.090
Why?
ROC Curve
1
2012
442
0.090
Why?
Electrocardiography
1
2013
560
0.090
Why?
Hypnotics and Sedatives
1
2011
134
0.090
Why?
Chemoprevention
1
2011
88
0.090
Why?
Ventilator Weaning
1
2010
33
0.090
Why?
Diet, Fat-Restricted
1
2010
73
0.090
Why?
Propofol
1
2010
43
0.090
Why?
Salvage Therapy
1
2011
127
0.090
Why?
Fatal Outcome
1
2011
284
0.090
Why?
Thalidomide
1
2010
29
0.090
Why?
Aortic Coarctation
1
2011
70
0.090
Why?
Molecular Targeted Therapy
1
2013
347
0.090
Why?
Lymphoma
1
2011
177
0.090
Why?
Birth Weight
1
2013
440
0.090
Why?
Drainage
1
2010
151
0.090
Why?
Infusions, Intravenous
3
2018
371
0.080
Why?
Kinetics
1
2013
1551
0.080
Why?
Device Removal
1
2010
126
0.080
Why?
Neoplasm Recurrence, Local
1
2014
859
0.080
Why?
Kidney
1
2016
1188
0.080
Why?
Plasmapheresis
1
2008
22
0.080
Why?
Alprostadil
1
2008
32
0.080
Why?
Diagnosis, Differential
1
2013
1342
0.080
Why?
High-Frequency Ventilation
1
2008
41
0.080
Why?
Antibodies, Monoclonal
2
2020
1264
0.080
Why?
Vincristine
3
2015
98
0.080
Why?
Adolescent
8
2018
17853
0.080
Why?
Adult
9
2022
30553
0.080
Why?
Renal Replacement Therapy
1
2008
66
0.080
Why?
Antibodies, Monoclonal, Humanized
1
2013
663
0.080
Why?
Neoadjuvant Therapy
1
2010
304
0.080
Why?
Aged
7
2020
19074
0.080
Why?
Doxorubicin
3
2015
285
0.070
Why?
Middle Aged
8
2020
26738
0.070
Why?
Kaplan-Meier Estimate
3
2015
811
0.070
Why?
Predictive Value of Tests
1
2012
1796
0.070
Why?
Transplantation, Autologous
2
2022
176
0.070
Why?
Patient Readmission
1
2012
610
0.070
Why?
Anticoagulants
1
2011
550
0.070
Why?
Interleukin-6
1
2010
676
0.070
Why?
Immunologic Factors
1
2008
220
0.070
Why?
Preoperative Care
1
2008
319
0.070
Why?
HIV Infections
1
2019
2469
0.060
Why?
Adrenal Cortex Hormones
1
2008
497
0.060
Why?
rho-Associated Kinases
1
2005
80
0.060
Why?
Immunosuppressive Agents
1
2008
646
0.060
Why?
Hemorrhage
1
2008
620
0.060
Why?
Attitude of Health Personnel
1
2011
975
0.060
Why?
Intracellular Signaling Peptides and Proteins
1
2005
388
0.050
Why?
Maximum Tolerated Dose
2
2014
183
0.050
Why?
Prednisone
2
2015
229
0.050
Why?
Melphalan
1
2022
29
0.050
Why?
Thrombocytopenia
2
2015
177
0.050
Why?
Lung Diseases
1
2008
701
0.050
Why?
Case-Control Studies
2
2019
3003
0.050
Why?
Severity of Illness Index
1
2008
2540
0.050
Why?
Viscera
1
2020
15
0.040
Why?
Immunoglobulin Light Chains
1
2020
36
0.040
Why?
Immunoglobulin Heavy Chains
1
2020
72
0.040
Why?
Cellulitis
1
2020
45
0.040
Why?
Nervous System
1
2020
63
0.040
Why?
Heart Failure
1
2012
1945
0.040
Why?
South Africa
1
2019
161
0.040
Why?
Cardiopulmonary Bypass
1
2020
178
0.040
Why?
Postoperative Period
1
2018
289
0.040
Why?
Rats
1
2005
4958
0.040
Why?
Anti-Retroviral Agents
1
2019
207
0.040
Why?
Infant Mortality
1
2018
91
0.040
Why?
Thrombelastography
1
2018
180
0.040
Why?
Ultrasonography
1
2019
634
0.030
Why?
Comorbidity
1
2020
1448
0.030
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2018
299
0.030
Why?
Disease Progression
1
2022
2380
0.030
Why?
Pneumonia
1
2020
568
0.030
Why?
Peripheral Nervous System Diseases
1
2015
120
0.030
Why?
Hydroxamic Acids
1
2014
80
0.030
Why?
Gastrointestinal Diseases
1
2015
182
0.030
Why?
Hyperbilirubinemia
1
2013
14
0.030
Why?
Longitudinal Studies
1
2019
2387
0.030
Why?
Liver Failure
1
2013
75
0.030
Why?
Indoles
1
2014
304
0.020
Why?
Administration, Oral
1
2014
728
0.020
Why?
Neutropenia
1
2013
125
0.020
Why?
Ventricular Function, Right
1
2014
250
0.020
Why?
Chemical Fractionation
1
2011
28
0.020
Why?
Neural Conduction
1
2012
78
0.020
Why?
Cytarabine
1
2011
51
0.020
Why?
Antineoplastic Agents
1
2022
1879
0.020
Why?
Neurologic Examination
1
2011
114
0.020
Why?
Multiple Organ Failure
1
2012
146
0.020
Why?
Risk Assessment
1
2020
2968
0.020
Why?
Prostaglandins
1
2011
77
0.020
Why?
Survival Analysis
1
2014
1211
0.020
Why?
Benzylamines
1
2011
39
0.020
Why?
Mouth
1
2011
70
0.020
Why?
Liver Cirrhosis
1
2013
227
0.020
Why?
Antigens, CD34
1
2011
89
0.020
Why?
Granulocyte Colony-Stimulating Factor
1
2011
71
0.020
Why?
Blood Component Removal
1
2011
29
0.020
Why?
Internationality
1
2011
143
0.020
Why?
Double-Blind Method
1
2014
1660
0.020
Why?
Recurrence
1
2013
935
0.020
Why?
Electroencephalography
1
2011
362
0.020
Why?
Aged, 80 and over
1
2020
6347
0.020
Why?
Animals
2
2010
31709
0.020
Why?
Cost-Benefit Analysis
1
2011
544
0.020
Why?
Hematopoietic Stem Cells
1
2011
343
0.020
Why?
Hospital Mortality
1
2012
776
0.020
Why?
Internet
1
2011
596
0.020
Why?
Young Adult
2
2011
10471
0.020
Why?
Liver
1
2013
1637
0.020
Why?
Mice, Inbred C57BL
1
2010
4694
0.010
Why?
United States
1
2011
12186
0.010
Why?
Mice
1
2010
14872
0.010
Why?
Kaufman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)